Everything is Awesome!

Where Do Brains Come From? Part II: Everything is Awesome!

Stories about evolution are compelling because they fit with our very human need for a linear narrative, but evolution possesses distinctive non-linearities driven by its agent, natural selection. Continue reading

Posted in About Neuroscience, Brain Basics, by Dwayne Godwin, Evolution, Genetics, Neuroanatomy, Policymakers, Sensing, Thinking & Behaving
Posted by Dwayne Godwin        Comment

Sex in Science: The NIH Gets it Wrong?

Beginning on October 1, researchers seeking NIH grants must balance male and female cells and animals in their NIH funded research. Under the banner of ending sex bias, this new mandate appears to be a significant advance in the way research is done, but many scientists fear the well-intentioned directive is misguided. Continue reading

Posted in About Neuroscience, Animal Research, by Douglas Fields, Neuroethics, Press, Uncategorized
Posted by Douglas Fields        1 Comment

Perception and Imagination: a Neuroscientist’s Perspective

When you look at the image of the apple on your computer monitor, an apple exists in two places: as a picture on your monitor and as an activation pattern in your brain. If you close your eyes and imagine an apple, an apple exists, but only in one place — in your brain. Continue reading

Posted in About Neuroscience, by John Kubie, Senses and Perception
Posted by John Kubie        1 Comment

Seven Big Brain Stories of 2013

What were the biggest neuroscience stories of 2013? It may be years before we gain the perspective to know for sure. But here’s a list of top contenders, and one of dubious value.

Continue reading

Posted in About Neuroscience, Aging, Brain Basics, by Dwayne Godwin, Childhood Disorders, Degenerative Disorders, Educators, Injury, Policymakers, Press, Sleep, Stress and Anxiety, Technologies
Posted by Dwayne Godwin        Comment

Ladies out of Luck: FDA Blocks “Female Viagra”

Guys who need it have Viagra; Ladies with the similar needs have nothing now that the FDA has denied approval of a new drug, flibanserin, which would treat sexual dysfunction in women. What’s interesting from a neuroscience perspective is how the drug works.  What’s interesting from a social perspective is how difficult it is to address this medical concern in women pharmacologically. Continue reading

Posted in Aging, Animal Research, by Douglas Fields, Chemicals, Mood, Neural Network Function, Neuroanatomy, Policymakers, Psychiatric Disorders, Stress and Anxiety, Uncategorized
Posted by Douglas Fields        Comment